215 related articles for article (PubMed ID: 31679247)
1. Polymeric Micelles for the Treatment of Rheumatoid Arthritis.
Yun L; Shang H; Gu H; Zhang N
Crit Rev Ther Drug Carrier Syst; 2019; 36(3):219-238. PubMed ID: 31679247
[TBL] [Abstract][Full Text] [Related]
2. Drug delivery targets and systems for targeted treatment of rheumatoid arthritis.
Feng X; Chen Y
J Drug Target; 2018 Dec; 26(10):845-857. PubMed ID: 29376442
[TBL] [Abstract][Full Text] [Related]
3. Enhanced Therapeutic Effect of RGD-Modified Polymeric Micelles Loaded With Low-Dose Methotrexate and Nimesulide on Rheumatoid Arthritis.
Wang Y; Liu Z; Li T; Chen L; Lyu J; Li C; Lin Y; Hao N; Zhou M; Zhong Z
Theranostics; 2019; 9(3):708-720. PubMed ID: 30809303
[TBL] [Abstract][Full Text] [Related]
4. Methotrexate: a gold standard for treatment of rheumatoid arthritis.
Shinde CG; Venkatesh MP; Kumar TM; Shivakumar HG
J Pain Palliat Care Pharmacother; 2014 Dec; 28(4):351-8. PubMed ID: 25322199
[TBL] [Abstract][Full Text] [Related]
5. Folate receptor-targeted mixed polysialic acid micelles for combating rheumatoid arthritis: in vitro and in vivo evaluation.
Zhang N; Xu C; Li N; Zhang S; Fu L; Chu X; Hua H; Zeng X; Zhao Y
Drug Deliv; 2018 Nov; 25(1):1182-1191. PubMed ID: 29790372
[TBL] [Abstract][Full Text] [Related]
6. Targeted drug-delivery systems in the treatment of rheumatoid arthritis: recent advancement and clinical status.
Gorantla S; Singhvi G; Rapalli VK; Waghule T; Dubey SK; Saha RN
Ther Deliv; 2020 Apr; 11(4):269-284. PubMed ID: 32434463
[TBL] [Abstract][Full Text] [Related]
7. Current understanding of rheumatoid arthritis therapy.
Colmegna I; Ohata BR; Menard HA
Clin Pharmacol Ther; 2012 Apr; 91(4):607-20. PubMed ID: 22357455
[TBL] [Abstract][Full Text] [Related]
8. Current Developments in Therapeutic Drug Targeting for the Management of Rheumatoid Arthritis: An Emerging Paradigm.
Pai DR; Venkatesh MP; Kumar TMP
Crit Rev Ther Drug Carrier Syst; 2019; 36(6):485-536. PubMed ID: 32421953
[TBL] [Abstract][Full Text] [Related]
9. Endogenous sialic acid-engineered micelles: a multifunctional platform for on-demand methotrexate delivery and bone repair of rheumatoid arthritis.
Xu XL; Li WS; Wang XJ; Du YL; Kang XQ; Hu JB; Li SJ; Ying XY; You J; Du YZ
Nanoscale; 2018 Feb; 10(6):2923-2935. PubMed ID: 29369319
[TBL] [Abstract][Full Text] [Related]
10. Methotrexate in the Treatment of Psoriasis and Rheumatoid Arthritis: Mechanistic Insights, Current Issues and Novel Delivery Approaches.
Rajitha P; Biswas R; Sabitha M; Jayakumar R
Curr Pharm Des; 2017; 23(24):3550-3566. PubMed ID: 28571554
[TBL] [Abstract][Full Text] [Related]
11. Notch-1 siRNA and Methotrexate towards a Multifunctional Approach in Rhematoid Arthritis Management: a Nanomedicine Approach.
Zhao G; Zhang H
Pharm Res; 2018 Apr; 35(6):123. PubMed ID: 29679159
[TBL] [Abstract][Full Text] [Related]
12. A Lipid Micellar System Loaded with Dexamethasone Palmitate Alleviates Rheumatoid Arthritis.
Wang X; Feng Y; Fu J; Wu C; He B; Zhang H; Wang X; Dai W; Sun Y; Zhang Q
AAPS PharmSciTech; 2019 Oct; 20(8):316. PubMed ID: 31602546
[TBL] [Abstract][Full Text] [Related]
13. Biomimetic hydroxyapatite as potential polymeric nanocarrier for the treatment of rheumatoid arthritis.
Ain Q; Zeeshan M; Khan S; Ali H
J Biomed Mater Res A; 2019 Dec; 107(12):2595-2600. PubMed ID: 31373751
[TBL] [Abstract][Full Text] [Related]
14. Dual-Stimuli Responsive Polymeric Micelles for the Effective Treatment of Rheumatoid Arthritis.
He L; Qin X; Fan D; Feng C; Wang Q; Fang J
ACS Appl Mater Interfaces; 2021 May; 13(18):21076-21086. PubMed ID: 33913684
[TBL] [Abstract][Full Text] [Related]
15. New autoinjector technology for the delivery of subcutaneous methotrexate in the treatment of rheumatoid arthritis.
Schiff M; Jaffe J; Freundlich B; Madsen P
Expert Rev Med Devices; 2014 Sep; 11(5):447-55. PubMed ID: 24934630
[TBL] [Abstract][Full Text] [Related]
16. Targeted delivery of low-dose dexamethasone using PCL-PEG micelles for effective treatment of rheumatoid arthritis.
Wang Q; Jiang J; Chen W; Jiang H; Zhang Z; Sun X
J Control Release; 2016 May; 230():64-72. PubMed ID: 27057749
[TBL] [Abstract][Full Text] [Related]
17. Targeting Pathways and Integrated Approaches to Treat Rheumatoid Arthritis.
Dwivedi SD; Yadav K; Bhoi A; Sahu KK; Sangwan N; Singh D; Singh MR
Crit Rev Ther Drug Carrier Syst; 2024; 41(4):87-102. PubMed ID: 38305342
[TBL] [Abstract][Full Text] [Related]
18. A hyaluronic acid-methotrexate conjugate for targeted therapy of rheumatoid arthritis.
Shin JM; Kim SH; Thambi T; You DG; Jeon J; Lee JO; Chung BY; Jo DG; Park JH
Chem Commun (Camb); 2014 Jul; 50(57):7632-5. PubMed ID: 24893961
[TBL] [Abstract][Full Text] [Related]
19. A systematic review of the effectiveness of adalimumab, etanercept and infliximab for the treatment of rheumatoid arthritis in adults and an economic evaluation of their cost-effectiveness.
Chen YF; Jobanputra P; Barton P; Jowett S; Bryan S; Clark W; Fry-Smith A; Burls A
Health Technol Assess; 2006 Nov; 10(42):iii-iv, xi-xiii, 1-229. PubMed ID: 17049139
[TBL] [Abstract][Full Text] [Related]
20. Nano-platform Strategies of Herbal Components for the Management of Rheumatoid Arthritis: A Review on the Battle for Next-Generation Formulations.
Prabha J; Kumar M; Kumar D; Chopra S; Bhatia A
Curr Drug Deliv; 2024; 21(8):1082-1105. PubMed ID: 37622715
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
